Atassi M Z, Manshouri T
Verna and Marrs McLean Department of Biochemistry, Baylor College of Medicine, Houston, TX 77030.
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8282-6. doi: 10.1073/pnas.90.17.8282.
Two 29-residue peptides were prepared, one of which (ChPepz) was designed by surface-simulation synthesis to mimic the active site of alpha-chymotrypsin, and the other (TrPepz), which contained four substitutions relative to ChPepz, was fashioned after the active site of trypsin. Each peptide was cyclized by a disulfide bond. The ChPepz monomer effected hydrolysis of the ester group in N-benzoyl-L-tyrosine ethyl ester, an alpha-chymotrypsin substrate, with Km and kcat values that were comparable to those of alpha-chymotrypsin. ChPepz was completely inactivated by diisopropyl fluorophosphate (DIFP), L-1-p-tosylamino-2-phenylethyl chloromethyl ketone (TPCK), or reduction of the disulfide bond. It had no catalytic activity on N-tosyl-L-arginine methyl ester, a trypsin substrate. On the other hand, TrPepz, which had no effect on N-benzoyl-L-tyrosine ethyl ester, hydrolyzed N-tosyl-L-arginine methyl ester with a Km value that was essentially identical to that of trypsin, but its kcat value was almost half that of trypsin. TrPepz was fully inactivated by reduction of the disulfide bond, by DIFP, or by phenylmethylsulfonyl fluoride but not by TPCK. It was also completely inhibited by soybean trypsin inhibitor, bovine pancreatic trypsin inhibitor, and human alpha 1-antitrypsin. ChPepz and TrPepz hydrolyzed proteins (myoglobin and casein) to give panels of peptides that were similar to those of the same protein obtained with the respective enzyme. However, TrPepz was more efficient than trypsin at hydrolyzing the C bonds of two or more consecutive lysine and/or arginine residues. Like its esterase activity, the proteolytic activity of ChPepz was inhibited by either DIFP or TPCK whereas that of TrPepz was inhibited by either DIFP or phenylmethylsulfonyl fluoride but not by TPCK. Finally, ChPepz and TrPepz were each more active at low temperature than the respective enzyme. This ability to construct fully functional peptide enzymes (pepzymes) of chosen specificities should find many practical applications.
制备了两种由29个氨基酸残基组成的肽,其中一种(ChPepz)是通过表面模拟合成设计的,用于模拟α-胰凝乳蛋白酶的活性位点,另一种(TrPepz)相对于ChPepz有四处替换,是按照胰蛋白酶的活性位点构建的。每种肽都通过二硫键环化。ChPepz单体对α-胰凝乳蛋白酶的底物N-苯甲酰-L-酪氨酸乙酯中的酯基进行水解,其Km和kcat值与α-胰凝乳蛋白酶相当。ChPepz可被二异丙基氟磷酸酯(DIFP)、L-1-对甲苯磺酰胺基-2-苯乙基氯甲基酮(TPCK)或二硫键还原完全失活。它对胰蛋白酶的底物N-甲苯磺酰-L-精氨酸甲酯没有催化活性。另一方面,TrPepz对N-苯甲酰-L-酪氨酸乙酯没有作用,但能水解N-甲苯磺酰-L-精氨酸甲酯,其Km值与胰蛋白酶基本相同,但其kcat值几乎是胰蛋白酶的一半。TrPepz可通过二硫键还原、DIFP或苯甲基磺酰氟完全失活,但不能被TPCK失活。它也完全被大豆胰蛋白酶抑制剂、牛胰蛋白酶抑制剂和人α1-抗胰蛋白酶抑制。ChPepz和TrPepz对蛋白质(肌红蛋白和酪蛋白)进行水解,得到的肽段与用相应酶处理同一蛋白质得到的肽段相似。然而,在水解两个或更多连续赖氨酸和/或精氨酸残基的C键时,TrPepz比胰蛋白酶更有效。与其酯酶活性一样,ChPepz的蛋白水解活性被DIFP或TPCK抑制,而TrPepz的蛋白水解活性被DIFP或苯甲基磺酰氟抑制,但不被TPCK抑制。最后,ChPepz和TrPepz在低温下的活性均高于相应的酶。构建具有特定功能的全功能肽酶(pepzyme)的这种能力应该会有许多实际应用。